Organon & Co. advanced stock charts by Barron's. View OGN historical stock data and compare to other stocks, and exchanges.

BofA analyst Jason Gerberry lowered the firm’s price target on Organon (OGN) to $10 from $11 and keeps an Underperform rating ...

A humorous look at the companies that caught our eye, for better or worse, this week ...

A Closer Look at Today's Losers in the Healthcare Sector ...

Organon stock cut their dividend by over 90%. There are lessons here for all income investors. Click here to find out what ...

Shares of Organon & Co. fell to a record low on Thursday after a series of analyst downgrades and price target cuts followed ...

The DJS Law Group announces that it is investigating claims on behalf of investors of Organon & Co. ("Organon" or "the Company") for violations of the securities laws. INVESTIGATION DETAILS: The ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for ...

Organon & Co's quarterly results showed a noticeable drop in EPS, which was lower than both the previous year's figure and the upper end of analyst projections. The company's revenue also experienced ...

Pharmaceutical company Organon (NYSE:OGN) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell ...

The Jersey City, N.J., pharmaceutical company cut its quarterly dividend to 2 cents a share, down from the prior 28 cents a share. Chief Executive Kevin Ali said the company reset its ...

Organon (OGN) stock dropped 13% after the company's Q1 results indicated its plans to cut dividends to $0.02/share amid a ...